US Products By Brand

Primary tabs

At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies, providing quality generics and biosimilars, and finding new ways to deliver these treatments to as many people as possible.

Products are listed alphabetically by brand name. This is not complete medical or product information. Click on the highlighted links next to the product names for complete prescribing information, including important safety information.

If you have a medical condition, promptly see your physician or other healthcare provider.

ADAKVEO® (crizanlizumab-tmca)

injection, for intravenous use

AFINITOR® (everolimus)

tablets for oral administration

AFINITOR® DISPERZ (everolimus tablets for oral suspension)

AIMOVIG® (erenumab-aooe)

injection, for subcutaneous use

Alomide® (lodoxamide tromethamine ophthalmic solution) 0.1%

Argatroban injection (for intravenous infusion only)

Arranon® (nelarabine)


Arzerra® (ofatumumab)

injection, for intravenous use

Azopt® (brinzolamide ophthalmic suspension) 1%